Heidelberg Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Heidelberg Pharma has a total shareholder equity of €35.8M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €65.8M and €30.0M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €36.57m |
| Equity | €35.82m |
| Total liabilities | €29.95m |
| Total assets | €65.77m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0QW5's short term assets (€52.4M) exceed its short term liabilities (€8.7M).
Long Term Liabilities: 0QW5's short term assets (€52.4M) exceed its long term liabilities (€21.2M).
Debt to Equity History and Analysis
Debt Level: 0QW5 is debt free.
Reducing Debt: 0QW5 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0QW5 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0QW5 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.2% each year